Cargando…

Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring: Some Additional Information

Detalles Bibliográficos
Autor principal:	Patel, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122049/ https://www.ncbi.nlm.nih.gov/pubmed/21731365 http://dx.doi.org/10.4103/0975-1483.80310

Ejemplares similares

Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring
por: Jeetu, G, et al.
Publicado: (2010)

Pharmacovigilance in drugs used in the treatment of drug dependence
por: Thota, Anusha, et al.
Publicado: (2017)

Pharmacovigilance in vaccines
por: Budhiraja, Salil, et al.
Publicado: (2010)

Pharmacovigilance on olanzapine
por: Lingeswaran, Anand, et al.
Publicado: (2010)

Medical and Demographic Analysis of Health Status of the Population of Some Countries Worldwide
por: TURGAMBAYEVA, Assiya, et al.
Publicado: (2019)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education
por: Khan, Zakir, et al.
Publicado: (2020)

Auscultation of the respiratory system — some additional points
por: Ray, Animesh
Publicado: (2015)

Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey
por: Khan, Zakir, et al.
Publicado: (2022)

Good Pharmacovigilance Practice: Accountability of Ayurvedic Pharmaceutical Companies
por: Sharma, Rohit, et al.
Publicado: (2017)

Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database
por: Campillo, Jeremy T., et al.
Publicado: (2022)

Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

International Society of Pharmacovigilance monitors vaccine safety
Publicado: (2022)

Good pharmacovigilance practice: Need of the hour from pharmaceutical companies
por: Bhati, Neha, et al.
Publicado: (2015)

Safety monitoring of local anaesthetic drugs from the perspective of Pharmacovigilance Programme of India
por: Kumar, Pramod, et al.
Publicado: (2017)

An opinion on the impacts of COVID-19 worldwide
por: Speth, Robert C.
Publicado: (2022)

Additional Information Regarding the SEVITENSION Study
por: Ruilope, Luis
Publicado: (2014)

Worldwide Prevalence of Head Lice
por: Falagas, Matthew E., et al.
Publicado: (2008)

Response to “Twitter-Based Journal Clubs: Some Additional Facts and Clarifications”
por: Perera, Marlon, et al.
Publicado: (2015)

Role of a medical advisor in pharmacovigilance as a business support service
por: Dang, Amit, et al.
Publicado: (2015)

The future role of pharmacists and pharmacovigilance after the advent of the COVID-19 pandemic
por: La Gatta, A., et al.
Publicado: (2021)

The future role of pharmacists and pharmacovigilance after the advent of the COVID-19 pandemic
por: La Gatta, A., et al.
Publicado: (2021)

A Call to Enhance Active and Transparent Pharmacovigilance for COVID-19 Vaccines
por: Kunene, Khontile Nobuhle, et al.
Publicado: (2023)

Drug safety guidelines: Are they effective?
por: Ahmad, Akram, et al.
Publicado: (2013)

Proportion of Mortality Attributable to Tobacco Worldwide
por: KHAZAEI, Salman, et al.
Publicado: (2016)

Worldwide Experiences in Disaster Medicine Education
por: Ragazzoni, Luca, et al.
Publicado: (2020)

Reply to “Key Points to Consider When Evaluating Andexxa for Formulary Addition”
por: Mahan, Charles E.
Publicado: (2020)

Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance”
por: Giugliano, Robert P., et al.
Publicado: (2021)

Cluster headache after COVID-19 vaccination with Comirnaty: A signal in pharmacovigilance database()
por: Rochoy, Michaël, et al.
Publicado: (2022)

Active Pharmacovigilance Study: A Follow-Up Model of Oral Anti-Cancer Drugs under Additional Monitoring
por: Carvalho da Silva, Sofia Pinto, et al.
Publicado: (2023)

Pharmacovigilance in the medical education: In UG curriculum where do we stand? What can be done?
por: Nanjundappa, Shiva Murthy, et al.
Publicado: (2023)

Impact of COVID-19 pandemic on the worldwide burden of tinnitus
por: Nocini, Riccardo, et al.
Publicado: (2022)

Information on vaccination safety on internet
por: Yasri, Sora, et al.
Publicado: (2018)

Pharmacovigilance: Safety matters…
por: Biswas, Pipasha
Publicado: (2008)

Informed Consent for Surgery During COVID-19: Some Important Issues
por: Wiwanitkit, Viroj
Publicado: (2020)

Worldwide contribution of Indian authors in various anesthesia-related journals
por: Kapoor, Indu, et al.
Publicado: (2016)

Status of adverse drug reaction monitoring and pharmacovigilance in selected countries
por: Yadav, Sachdev
Publicado: (2008)

Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance
por: Sahu, Ram Kumar, et al.
Publicado: (2014)

The Need to Use Mortality, and Not Case-Fatality, to Compare COVID-19 Deaths Worldwide
por: Silveira, Erika A., et al.
Publicado: (2022)

The need for greater opioid pharmacovigilance in COPD
por: Vozoris, Nicholas T
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vr70q70iv5u7hbtjuf24giou3d